GSK-3
GSK3 (glycogen synthase kinase-3) is a serine/threonine protein kinase which contributes to cell survival, diabetes, insulin resistance and Alzheimer's diseases.
- Cat.No. Product Name Information
-
GC13907
1-Azakenpaullone
GSK-3β inhibitor,potent and selective,cell-permeable
-
GC14306
3F8
GSK-3β inhibitor
-
GC35162
5-Iodo-indirubin-3’-monoxime
5-Iodo-indirubin-3'-monoxime 是一种有效的 GSK-3β,CDK5/P25 和 CDK1/cyclin B 抑制剂,与 ATP 竞争性地结合酶的催化位点,IC50 值分别为 9,20 和 25 nM。
-
GC39152
9-ING-41
9-ING-41 是一个有效的糖原合酶激酶 3 (GSK-3) 抑制剂。9-ING-41 通过靶向中心体和微管结合的 GSK-3β 诱导前期凋亡和细胞周期停滞。9-ING-41 具有抗肿瘤活性。
-
GC10336
A 1070722
GSK-3 inhibitor
-
GC15841
Alsterpaullone
CDKs and GSK3β inhibitor
-
GC15425
AR-A014418
GSK3β inhibitor, ATP-competitive and selective
-
GC16568
AZD1080
GSK3βinhibitor
-
GC14736
AZD2858
GSK-3 inhibitor,potent and selective
-
GC10752
Bikinin
GSK3 inhibitor and Brassinosteroid activator
-
GC14233
BIO-acetoxime
GSK-3α/β inhibitor
-
GC38892
BIP-135
BIP-135 是一个高效、选择性的,ATP 竞争性的 GSK-3 抑制剂,对 GSK-3α 和 GSK-3β 作用的IC50 值分别为 16 nM 和 21 nM。BIP 135 具有神经保护作用。
-
GC39181
BRD0705
BRD0705 是一种有效的,具有旁系选择性和口服活性的 GSK3α 抑制剂,IC50 为 66 nM,Kd 为 4.8 μM。 BRD0705 与 GSK3β (IC50 为 515 nM) 相比,对 GSK3α 的选择性更高 (8 倍)。BRD0705 可用于治疗急性髓细胞性白血病。
-
GC15642
CHIR 99021 trihydrochloride
glycogen synthase kinase 3 (GSK-3) inhibitor
-
GC12176
CHIR-98014
GSK-3β inhibitor,selective and ATP-competitive
-
GC16702
CHIR-99021 (CT99021)
GSK-3 inhibitor, Cell-permeable, ATP-competitive
-
GC17153
CHIR-99021 (CT99021) HCl
GSK-3α/β inhibitor
-
GC13176
CP21R7
GSK3β inhibitor
-
GC17690
Cromolyn sodium
Mast cell membrane stabilizer
-
GC17457
FRATide
GSK-3 inhibitor